Wetzel, Alexandra <br/><br/>
Epigenetic histone modulation contributes to improvements in inflammatory bowel disease via EBI3.  [electronic resource] 

 -  Cellular and molecular life sciences : CMLS  Dec 2020 
 - 5017-5030 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1420-9071 
<br/><br/><label>Standard No.: </label>10.1007/s00018-020-03451-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CD3 Complex--metabolism<br/>Caspase 3--metabolism<br/>Colitis--chemically induced<br/>Dextran Sulfate<br/>Epigenesis, Genetic--drug effects<br/>Histone Deacetylase Inhibitors--pharmacology<br/>Histones--metabolism<br/>Humans<br/>Inflammation--pathology<br/>Inflammatory Bowel Diseases--genetics<br/>Interleukin-12--metabolism<br/>Interleukins--genetics<br/>Mice, Inbred C57BL<br/>Minor Histocompatibility Antigens--genetics<br/>Phenotype<br/>Protein Binding--drug effects<br/>Receptors, Cytokine--genetics<br/>Signal Transduction--drug effects<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>Vorinostat--pharmacology